Huntington disease Trials in Rochester, United States
Conditions / Huntington disease / Rochester, United States
Clinical trials for Huntington disease investigate a range of treatment strategies and patient populations.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00920946 | A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease | COMPLETED | PHASE3 |
| NCT00271596 | Citalopram to Enhance Cognition in HD | COMPLETED | PHASE2 |
| NCT04201834 | Risperidone for the Treatment of Huntington's Disease Involuntary Movements | COMPLETED | PHASE2 |
| NCT00146211 | TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease | COMPLETED | PHASE3 |
| NCT00052143 | Prospective Huntington At Risk Observational Study | COMPLETED | — |
| NCT00313495 | Cooperative Huntington's Observational Research Trial | UNKNOWN | — |
| NCT07010705 | Digital Measures for Clinical Trial Endpoints in Huntington's Disease | RECRUITING | — |
| NCT07315984 | Multi-Modal Digital Monitoring of Disease Symptoms Huntington's Disease | NOT_YET_RECRUITING | — |
| NCT00277355 | Pilot Study of Minocycline in Huntington's Disease | COMPLETED | PHASE2/PHASE3 |
| NCT00724048 | A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease | COMPLETED | PHASE2 |